drugset
drugset / Trial / NCT04937920

A Trial to Evaluate the Safety and Antimicrobial Efficacy of DBI-002 Probiotic in Adults With Tinea Versicolor

NCT04937920 ↗

Phase 2 Completed 34 enrolled DermBiont, Inc.
RandomizedSequentialTriple-blindTreatment

Summary

A Randomized, Double-Blinded, Aqueous Gel-Controlled Dose Escalating Trial to Study the Safety and Antimicrobial Efficacy of DBI-002 Probiotic vs. Aqueous Gel and Vehicle Gel vs. Aqueous Gel in Adults with Tinea Versicolor (DBI-202).

Timeline

Start
2021-03-16
Primary completion
2021-09-20
Completion
2021-11-04

Drugs

EvaluationDrugModalityDoseRoute
Comparator DBI-002 Other / unclassified — Topical

Indications

pityriasis versicolor